Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Interest Expenses (2023 - 2026)

Phibro Animal Health has reported Interest Expenses over the past 6 years, most recently at $12.5 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 27.64% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $43.7 million, up 44.79%, while the annual FY2025 figure was $37.2 million, 61.77% up from the prior year.
  • Interest Expenses for Q4 2025 was $12.5 million at Phibro Animal Health, roughly flat from $12.5 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $12.5 million in Q3 2025 and troughed at $5.6 million in Q3 2023.
  • A 3-year average of $8.5 million and a median of $8.9 million in 2024 define the central range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 71.0% in 2025 and fell as far as 27.64% in 2025.
  • Year by year, Interest Expenses stood at $5.7 million in 2023, then surged by 70.85% to $9.8 million in 2024, then rose by 27.64% to $12.5 million in 2025.
  • Business Quant data shows Interest Expenses for PAHC at $12.5 million in Q4 2025, $12.5 million in Q3 2025, and $9.0 million in Q2 2025.